Metipranolol
- Level
- Commodity
- Parent
- 51263100
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51263126This classification denotes a beta-adrenergic blocking agent with the molecular formula C17H27NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier X39AL81KEB, chemically known as 4-(2-hydroxy-3-((1-methylethyl)-amino)propoxy)-2,3,6-trimethylphenol 1-acetate but generally known as metipranolol, which bears US NIH Compound Identifier 31477. European Medicines Agency schedules Metipranolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08892MIG. The term METIPRANOLOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 32, No 10 1978, List 18). World Health Organization schedules metipranolol in its Anatomical Therapeutic Chemical (ATC) Classification. METIPRANOLOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule metipranolol under HS 29221980 and SITC 51461. As of Q4 2014, METIPRANOLOL remains the US FDA Preferred Term for this commodity. Metipranolol bears US NLM identifiers UMLS ID C0041030 and NCI Concept Code C61844. SMILES: O(CC(O)CNC(C)C)C1C(C(C(OC(=O)C)C(C1)C)C)C.
Same parent
Under 51263100 · 75Activities that produce or sell this
KBLI · 8Inherited from family 51260000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.